ILOITO CITY – Twenty-eight standardized herbal drugs formulated under the Department of Science and Technology’s (DOST) Comprehensive Drug Discovery or “Tuklas Lunas” program are ready for preclinical and clinical testing in this medium. ‘year.
“We are conducting formulation studies with our pharmacists, hopefully by the middle of this year we will have 28 standardized herbal medicines formulated ready for preclinical and clinical testing,” said Dr Amelia Guevara, former undersecretary for research and development of DOST in a statement. press conference Tuesday.
She said researchers started formulating sometime in 2010, but continued in 2013 when funding for the project was released.
The formulations were passed from lab to lab as plant extracts found to be active by chemists were passed on to pharmacists for formulation, she said.
Guevara said the formulations are targets to become anti-cancer, anti-diabetes, anti-inflammatory and anti-hypertensive.
Dr Jonel Saludes, associate vice president for research and global relations at the University of San Agustin in that city, explained that the formulation is to “prepare plant extracts into something that can be taken or applied” .
“We are preparing something in a form that could be administered or for topical applications,” Saludes said at a press conference.
“We very much hope that in a year or two there will be several standardized drugs on the market,” she said, adding that the current administration wants many drugs to be reported by 2022.
Guevara said the department is short of researchers because most researchers are overloaded with projects and administrative work.
Despite this, she assured that the department is ready to fund research and good science. (ANP)